Skip to main content

PROFUNDIZANDO EN EL MECANISMO DE ACCION DE LOS INHIBIDORES DE PARP EN PACIENTES CON CANCER DE MAMA Y OVARIO. IDENTIFICACION DE MARCADORES GENETICOS PREDICTORES DE RESPUESTA.

SAF2014-57680-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A common SNP in the UNG gene decreases ovarian cancer risk in BRCA2 mutation carriers

  • Baquero, Juan Miguel
  • Benitez-Buelga, Carlos
  • Fernández, Victoria
  • Urioste, Miguel
  • García-Giménez, José Luis
  • Perona Abellón, Rosario
  • CIMBA Consortium
  • Benítez, Javier
  • Osorio, Ana
Single nucleotide polymorphisms (SNPs) in DNA glycosylase genes involved in the base excision repair (BER) pathway can modify breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. We previously found that SNP rs34259 in the uracil-DNA glycosylase gene (UNG) might decrease ovarian cancer risk in BRCA2 mutation carriers. In the present study, we validated this finding in a larger series of familial breast and ovarian cancer patients to gain insights into how this UNG variant exerts its protective effect. We found that rs34259 is associated with significant UNG downregulation and with lower levels of DNA damage at telomeres. In addition, we found that this SNP is associated with significantly lower oxidative stress susceptibility and lower uracil accumulation at telomeres in BRCA2 mutation carriers. Our findings help to explain the association of this variant with a lower cancer risk in BRCA2 mutation carriers and highlight the importance of genetic changes in BER pathway genes as modifiers of cancer susceptibility for BRCA1 and BRCA2 mutation carriers., JMB is supported by grant FPU15/01978 from the Spanish Ministry of Education, Culture, and Sport. CB-B is supported by the Spanish Ministry of Health FIS PI12/00070. This study was partially funded by the Spanish Ministry of Economy and Competitiveness (MINECO) SAF2014-57680-R. JB’s laboratory is partially funded by FIS PI16/00440 supported by FEDER funds and the Spanish Network on Rare Diseases (CIBERER). MU is supported by grant PI14/00459 from the European Regional Development Fund (ERDF). RP’s laboratory is funded by grant P14-01495 (Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain) supported by FEDER funds. JLG-G thanks the Instituto de Salud Carlos III for grant number PI16/01031, cofinanced by the European Regional Development Fund (ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

  • Rebbeck, Timothy R.
  • Friebel, Tara M.
  • Friedman, Eitan
  • Hamann, Ute
  • Huo, Dezheng
  • Kwong, Ava
  • Olah, Edith
  • Olopade, Olufunmilayo I.
  • Solano, Angela R.
  • Teo, Soo-Hwamg
  • Thomassen, Mads
  • Mebirouk, Noura
  • Meijers-Heijboer, Hanne
  • Meindl, Alfons
  • Mensenkamp, Arjen R.
  • Kruse, Torben A.
  • Benitez, Javier
  • Mickys, Ugnius
  • Greene, Mark H.
  • Miller, Austin
  • thomas, Abigail
  • Cook, Jackie
  • Montagna, Marco
  • Moysich, Kirsten B.
  • Mulligan, Anna Marie
  • Musinsky, Jacob
  • Neuhausen, Susan L.
  • Nevanlinna, Heli
  • Ngeow, Joanne
  • Berger, Andreas
  • Nguyen, Huu Phuc
  • Palmero, Edenir Inêz
  • Davidson, Rosemarie
  • Bonadona, Valérie
  • Schmutzler, Rita Katharina
  • Niederacher, Dieter
  • Nielsen, Henriette Roed
  • Nielsen, Finn Cilius
  • Nussbaum, Robert L.
  • Offit, Kenneth
  • Öfverholm, Anna
  • Ong, Kai-ren
  • Berger, Raanan
  • Hoya, Miguel de la
  • Osorio, Ana
  • Konstantopoulou, Irene
  • Papi, Laura
  • Papp, Janos
  • Senter, Leigha
  • Kyung Park, Sue
  • Pasini, Barbara
  • Pedersen, Inge Sokilde
  • Peixoto, Ana
  • Peruga, Nina
  • Leeneer, Kim de
  • Peterlongo, Paolo
  • Blanco, Amie M.
  • Thull, Darcy L.
  • Pohl, Esther
  • Pradhan, Nisha
  • Prajzendanc, Karolina
  • Prieur, Fabienne
  • Shah, Payal D.
  • Pujol, Pascal
  • Torres, Diana
  • Pauw, Antoine de
  • Radice, Paolo
  • Sharma, Priyanka
  • Side, Lucy E.
  • Tischkowitz, Marc
  • Blazer, Kathleen R.
  • Simard, Jacques
  • Singer, Christian F.
  • Skytte, Anne-Bine
  • Slavin, Thomas P.
  • Snape, Katie
  • Rashid, Muhammad Usman
  • Gronwald, Jacek
  • McGuffog, Lesley
  • Sobol, Hagay
  • Southey, Melissa
  • Tognazzo, Silvia
  • Steele, Linda
  • Blok, Marinus J.
  • Steinemann, Doris
  • Toland, Amanda Ewart
  • Topka, Sabine
  • Delnatte, Capucine
  • Trainer, Alison H.
  • Tung, Nadine
  • Hahnen, Eric
  • Asperen, Christi J. van
  • Hout, Annemieke H. van der
  • Korach, Jacob
  • Hogervorst, Frans B. L.
  • Leslie, Goska
  • Kolk, Lizet E. van der
  • Luijt, Rob B. van der
  • Weitzel, Jeffrey N.
  • Heetvelde, Mattias van
  • Varesco, Liliana
  • Varon-Mateeva, Raymonda
  • Vega, Ana I.
  • Villarreal-Garza, Cynthia
  • Hauke, Jan
  • Laitman, Yael
  • Wachenfeldt, Anna von
  • Ramus, Susan J.
  • Walker, Lisa
  • Díez, Orland
  • Wang-Gohrke, Shan
  • Aalfs, Cora M.
  • Wappenschmidt, Barbara
  • Weber, Bernhard H. F.
  • Yannoukakos, Drakoulis
  • Yoon, Sook-Yee
  • Zanzottera, Cristina
  • Lasa, Adrian
  • Zidan, Jamal
  • HEBON
  • Lee, Min Hyuk
  • Bonanni, Bernardo
  • Zorn, Kristin K.
  • Selkirk, Christina G. Hutten
  • Hulick, Peter J.
  • Chenevix-Trench, Georgia
  • Abugattas, Julio
  • Spurdle, Amanda B.
  • Antoniou, Antonis C.
  • Lasset, Christine
  • Nathanson, Katherine L.
  • Sukiennicki, Grzegorz
  • Adlard, Julian
  • Agata, Simona
  • Bradbury, Angela R.
  • Henderson, Alex
  • Aittomäki, Kristiina
  • Andrews, Lesley
  • Andrulis, Irene L.
  • Arason, Adalgeir
  • Arnold, Norbert
  • Couch, Fergus J.
  • Ding, Yuan Chun
  • Arun, Branu K.
  • Asseryanis, Ella
  • Auerbach, Leo
  • Azzollini, Jacopo
  • Brewer, Carole
  • Balmaña, Judith
  • Hentschel, Julia
  • Barile, Monica
  • Buecher, Bruno
  • Buys, Saundra S.
  • Ditsch, Nina
  • Lázaro, Conxi
  • Caldés, Trinidad
  • Caliebe, Almuth
  • Caligo, Maria A.
  • Campbell, Ian
  • Caputo, Sandrine M.
  • Rantala, Johanna
  • Honisch, Ellen
  • Chiquette, Jocelyne
  • Chung, Wendy K.
  • Domchek, Susan M.
  • Claes, Kathleen B.
  • Lee, Annette T.
  • Collée, J. Margriet
  • Evans, D. Gareth
  • Dorfling, Cecilia M.
  • Velázquez Pérez, Carolina
  • Dworniczak, Bernd
  • Eason, Jacqueline
  • Rhiem, Kerstin
  • Easton, Douglas F.
  • Eeles, Ros
  • Sutter, Christian
  • Schmidt, Ane Y.
  • Imyanitov, Evgeny N.
  • Ehrencrona, Hans
  • Ejlertsen, Bent
  • EMBRACE
  • Engel, Christoph
  • Engert, Stefanie
  • Faivre, Laurence
  • Feliubadaló, Lidia
  • Robson, Mark
  • szabo, Csilla I., Tan, Yen Y.
  • Fert Ferrer, Sandra
  • Barkardottir, Rosa B.
  • Foretova, Lenka
  • Fowler, Jeffrey
  • Isaacs, Claudine
  • Frost, Debra
  • Galvão, Henrique C. R.
  • Ganz, Patricia A.
  • Garber, Judy
  • Gauthier-Villars, Marion
  • Teixeira, Manuel R.
  • Gehrig, Andrea
  • Rodriguez, Gustavo C.
  • Lester, Jenny
  • GEMO Study Collaborators
  • Gerdes, Anne-Marie
  • Gesta, Paul
  • Giannini, Giuseppe
  • Izat, Louise
  • Giraud, Sophie
  • Glendon, Gord
  • Terry, Mary Beth
  • Godwin, Andrew K.
  • Izquierdo, Angel
  • Jakubowska, Anna
  • Lesueur, Fabienne
  • Rogers, Mark T.
  • James, Paul
  • Janavicius, Ramunas
  • Jensen, Uffe Birk
  • John, Esther M.
  • Vijai, Joseph
  • Gutierrez-Barrera, Angelica
  • Chan, T. L.
  • Kaczmarek, Katarzyna
  • Karlan, Beth Y.
  • Kast, Karin
  • Liljegren, Annelie
  • KConFab Investigators
  • Rudaitis, Vilius
  • Kim, Sung-Won
  • Lindor, Noralane M.
  • Longy, Michel
  • Teulé, Alex
  • Loud, Jennifer T.
  • Lu, Karen H.
  • Goldgar, David E.
  • Lubinski, Jan
  • Machackova, Eva
  • Barrowdale, Daniel
  • Rensburg, Elizabeth J. van
  • Manoukian, Siranoush
  • Mari, Véronique
  • Martínez-Bouzaz, Cristina
  • Parsons, Michael T.
  • Matrai, Zoltan
The prevalence and spectrum of germline mutations in BRCA1 and BRCA2 have been reported in single populations, with the majority of reports focused on White in Europe and North America. The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) has assembled data on 18,435 families with BRCA1 mutations and 11,351 families with BRCA2 mutations ascertained from 69 centers in 49 countries on six continents. This study comprehensively describes the characteristics of the 1,650 unique BRCA1 and 1,731 unique BRCA2 deleterious (disease-associated) mutations identified in the CIMBA database. We observed substantial variation in mutation type and frequency by geographical region and race/ethnicity. In addition to known founder mutations, mutations of relatively high frequency were identified in specific racial/ethnic or geographic groups that may reflect founder mutations and which could be used in targeted (panel) first pass genotyping for specific populations. Knowledge of the population-specific mutational spectrum in BRCA1 and BRCA2 could inform efficient strategies for genetic testing and may justify a more broad-based oncogenetic testing in some populations., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Coignard, Juliette
  • Beesley, Jonathan
  • O'Mara, Tracy A.
  • Diez Gibert, Orland
  • Lopez-Fernandez, Adrià
  • Dennis, Joe
  • Tyrer, Jonathan
  • Lush, Michael
Càncer de mama; Genètica del càncer; Factors de risc, Cáncer de mama; Genética del cáncer; Factores de riesgo, Breast cancer; Cancer genetics; Risk factors, Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Individuals with FANCM biallelic mutations do no develop Fanconi anemia, but show risk for breast cancer, chemotherapy sensitivity toxicity and may display chromosome fragility

  • Catucci, Irene
  • Osorio, Ana|||0000-0001-8124-3984
  • Arver, Brita
  • Neidhardt, Guido
  • Bogliolo, Massimo|||0000-0001-8240-7784
  • Zanardi, Federica
  • Riboni, Mirko
  • Minardi, Simone
  • Pujol Calvet, Maria Roser|||0000-0003-1840-5455
  • Azzollini, Jacopo
  • Peissel, Bernard|||0000-0001-9233-3571
  • Manoukian, Siranoush
  • Vecchi, De, Giovanna
  • Casola, Stefano
  • Hauke, Jan|||0000-0001-8236-4075
  • Richters, Lisa
  • Rhiem, Kerstin
  • Schmutzler, Rita K.
  • Wallander, Karin
  • Törngren, Therese
  • Borg, Åke
  • Radice, Paolo|||0000-0001-6298-4111
  • Surralles, Jordi|||0000-0002-4041-7519
  • Hahnen, Eric|||0000-0002-1152-8367
  • Ehrencrona, Hans|||0000-0002-5589-3622
  • Kvist, Anders
  • Benitez, Javier|||0000-0002-0923-7202
  • Peterlongo, Paolo|||0000-0001-6951-6855
PurposeMonoallelic germ-line mutations in the BRCA1/FANCS, BRCA2/FANCD1 and PALB2/FANCN genes confer high risk of breast cancer. Biallelic mutations in these genes cause Fanconi anemia (FA), characterized by malformations, bone marrow failure, chromosome fragility, and cancer predisposition (BRCA2/FANCD1 and PALB2/FANCN), or an FA-like disease presenting a phenotype similar to FA but without bone marrow failure (BRCA1/FANCS). FANCM monoallelic mutations have been reported as moderate risk factors for breast cancer, but there are no reports of any clinical phenotype observed in carriers of biallelic mutations.MethodsBreast cancer probands were subjected to mutation analysis by sequencing gene panels or testing DNA damage response genes.ResultsFive cases homozygous for FANCM loss-of-function mutations were identified. They show a heterogeneous phenotype including cancer predisposition, toxicity to chemotherapy, early menopause, and possibly chromosome fragility. Phenotype severity might correlate with mutation position in the gene.ConclusionOur data indicate that biallelic FANCM mutations do not cause classical FA, providing proof that FANCM is not a canonical FA gene. Moreover, our observations support previous findings suggesting that FANCM is a breast cancer-predisposing gene. Mutation testing of FANCM might be considered for individuals with the above-described clinical features.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Coignard, Juliette
  • Beesley, Jonathan
  • O'Mara, Tracy A.
  • Diez Gibert, Orland
  • Lopez Fernandez, Adrià
  • Dennis, Joe
  • Tyrer, Jonathan
  • Lush, Michael
Càncer de mama; Genètica del càncer; Factors de risc, Cáncer de mama; Genética del cáncer; Factores de riesgo, Breast cancer; Cancer genetics; Risk factors, Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.